Big Gain For Rocket Pharmaceuticals, Inc.
Wed, Dec 09, 2020 at 05:30 PM
Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ) shot up at $58.74, a gain of 83.4%. The stock got featured on our News Catalysts scanner on Wed 09 Dec 20 at 01:32 PM in the 'PATNERSHIP' category. From Tue 24 Nov 20, the stock recorded 66.67% Up Days and 70.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ)
Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.
Top 10 Gainers:
- GLSI (GLSI:NASDAQ), 998.08%
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 193.52%
- Arlington Asset Investment Corp. (AI:NYSE), 120.21%
- SV (SV:NASDAQ), 100%
- DoorDash Inc (DASH:NASDAQ), 85.79%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 83.39%
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 73.17%
- MTS Systems Corporation (MTSC:NASDAQ), 51.84%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 39.04%
- Tuscan Holdings Corp. (THCB:NASDAQ), 34.59%